Jump Financial LLC lifted its position in Oscar Health, Inc. (NYSE:OSCR – Free Report) by 57.4% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 562,376 shares of the company’s stock after buying an additional 204,985 shares during the quarter. Jump Financial LLC’s holdings in Oscar Health were worth $7,558,000 as of its most recent SEC filing.
A number of other hedge funds have also recently added to or reduced their stakes in the company. JPMorgan Chase & Co. grew its position in Oscar Health by 348.7% in the fourth quarter. JPMorgan Chase & Co. now owns 10,360,529 shares of the company’s stock worth $139,246,000 after acquiring an additional 8,051,379 shares in the last quarter. BIT Capital GmbH raised its holdings in Oscar Health by 5,711.6% during the fourth quarter. BIT Capital GmbH now owns 4,473,853 shares of the company’s stock valued at $60,129,000 after buying an additional 4,396,872 shares in the last quarter. Hennessy Advisors Inc. lifted its position in shares of Oscar Health by 550.3% in the fourth quarter. Hennessy Advisors Inc. now owns 4,188,400 shares of the company’s stock worth $56,292,000 after buying an additional 3,544,300 shares during the last quarter. Clearbridge Investments LLC acquired a new stake in shares of Oscar Health in the fourth quarter worth about $19,088,000. Finally, American Century Companies Inc. increased its holdings in shares of Oscar Health by 185.6% during the 4th quarter. American Century Companies Inc. now owns 1,285,204 shares of the company’s stock valued at $17,273,000 after acquiring an additional 835,144 shares during the last quarter. Institutional investors and hedge funds own 75.70% of the company’s stock.
Oscar Health Price Performance
Shares of NYSE:OSCR opened at $12.47 on Wednesday. The company has a market cap of $3.12 billion, a price-to-earnings ratio of -622.94 and a beta of 1.75. The business has a 50 day moving average price of $13.90 and a 200 day moving average price of $15.24. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.26. Oscar Health, Inc. has a twelve month low of $11.47 and a twelve month high of $23.79.
Analysts Set New Price Targets
Separately, Wells Fargo & Company lowered Oscar Health from an “overweight” rating to an “equal weight” rating and reduced their target price for the stock from $20.00 to $16.00 in a report on Thursday, March 13th. Two research analysts have rated the stock with a sell rating, three have given a hold rating, two have assigned a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus target price of $20.21.
Read Our Latest Stock Analysis on Oscar Health
Oscar Health Profile
Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.
See Also
- Five stocks we like better than Oscar Health
- The Risks of Owning Bonds
- Beware of BigBear.ai: Insiders Are Selling—Should You?
- Following Congress Stock Trades
- CrowdStrike Stock is a Buy as Cyberthreat Environment Expands
- Upcoming IPO Stock Lockup Period, Explained
- Congress! Who Traded What During the Tariff-Induced MeltdownÂ
Want to see what other hedge funds are holding OSCR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Oscar Health, Inc. (NYSE:OSCR – Free Report).
Receive News & Ratings for Oscar Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oscar Health and related companies with MarketBeat.com's FREE daily email newsletter.